ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,349, issued on Dec. 16, was assigned to BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (Lincoln, Neb.).

"Macromolecular prodrug-based thermosensitive injectable gel as a novel drug delivery platform" was invented by Dong Wang (Omaha, Neb.), Steven R. Goldring (Auburndale, Mass.), Gang Zhao (Omaha, Neb.), Rongguo Ren (Omaha, Neb.), Zhenshan Jia (Omaha, Neb.) and Xin Wei (Omaha, Neb.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application discloses prodrug-based thermosensitive gel ("ProGel") comprised of conjugates of dmg molecules with water-soluble polymeric carriers, which are capable of controlled release of the dmg molecules into the tis...